FRONTIER CAPITAL MANAGEMENT CO LLC – CRISPR Therapeutics AG Transaction History
FRONTIER CAPITAL MANAGEMENT CO LLC portfolio value:
$20.84M
portfolio value
FRONTIER CAPITAL MANAGEMENT CO LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +89.28% | 150.42K shares | 10.60M | $65.35 | 318.91K |
| Q2 2022 | share | Increase | +13.91% | 20.56K shares | 954K | $60.77 | 168.48K |
| Q1 2022 | share | Increase | 0.00% | 147.91K shares | 9.28M | $62.77 | 147.91K |
| Q1 2021 | share | Decrease | -100.00% | -3.18K shares | -488K | $121.85 | 0 |
| Q4 2020 | share | Decrease | -0.03% | -1 shares | 221K | $153.11 | 3.18K |
| Q3 2020 | share | Decrease | -98.00% | -156.27K shares | -11.45M | $83.64 | 3.18K |
| Q2 2020 | share | Increase | +38.52% | 44.34K shares | 6.83M | $73.49 | 159.45K |
| Q1 2020 | share | Increase | +50.21% | 38.47K shares | 214K | $42.41 | 115.11K |
| Q4 2019 | share | Increase | 0.00% | 76.63K shares | 4.66M | $60.91 | 76.63K |
| Q3 2018 | share | Decrease | -100.00% | -54.63K shares | -3.21M | $44.35 | 0 |
| Q2 2018 | share | Increase | 0.00% | 54.63K shares | 3.21M | $58.76 | 54.63K |